Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 30;10:1088823. doi: 10.3389/fchem.2022.1088823

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Miao, Ti, Lu, Zhao, Xu, Chen and Bao.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

In vivo antitumor efficacy of CDDP@m-CuS-PEG on metastasized breast cancer therapy. (A) Tumor volumes relative to the start point in each group collected on day 14, sample size: n = 4. (B) Images of tumor-bearing mice on days 2, 4, 6, 8, 10, 12 and 14. (C) Weight changes curve within 14-day treatments of each group, sample size: n = 4; (D) H&E staining of tumor sections in each group. Scale bars = 100 μm for H&E.